"In Stevens Point, Wisconsin, Ascension St. Michael's Emergency Department delivers 24/7 emergency care for serious and life-threatening injuries and illnesses. We listen to quickly understand your health needs. Then, we provide care that’s right for you. Board-certified emergency care doctors and care teams at Ascension are trained in advanced life-saving services. From the moment you walk through the door, we deliver compassionate care to help you and your loved ones through an emergency."

During the past decade, Ascension Saint Michael's Hospital conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 71 clinical trials were completed, i.e. on average, 139.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 42 clinical trials were completed. i.e. 381.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint Michael's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Gynecologic Oncology Group" with 8 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint Michael's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint Michael's Hospital" are "Fallopian Tube Transitional Cell Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Ovarian Transitional Cell Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Ascension Saint Michael's Hospital" in a lesser frequency.

Most popular intervention types in "Ascension Saint Michael's Hospital" are "Drug" (100 trials), "Other" (93 trials), "Biological" (55 trials), "Procedure" (22 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (66 trials), "Quality-of-Life Assessment" (36 trials), "Paclitaxel" (22 trials), "Bevacizumab" (18 trials) and "Carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint Michael's Hospital" are 95 trials for "All" genders, 24 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Saint Michael's Hospital". undefined are not yet recruiting, 18 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Ascension Saint Michael's Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint Michael's Hospital, 2 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".